Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Xuekun Nie"'
Autor:
Xiaolan Lai, Chuanqian Huang, Xuekun Nie, Qi Chen, Yirong Tang, Xianguo Fu, Ying Lin, Chengjun Nie, Xinyu Xu, Xiukang Wang, Renli Chen, Zichun Chen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Multiple myeloma (MM) is a malignant cancer with an increasing in incidence that can be alleviated through bortezomib (BTZ) treatment. Activating transcription factor 3 (ATF3) plays a major role in cancer development. Moreover, microRNAs (miRNAs) reg
Externí odkaz:
https://doaj.org/article/1f0d65ff4b39436da93b8fc8fd31ef23
Publikováno v:
J Thorac Dis
BACKGROUND: The effect of empagliflozin on the cardiovascular outcome is consistent in heart failure with reduced ejection fraction (HFrEF) patients regardless of the presence or absence of diabetes. More evidence is needed regarding the cost-effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed7d1185708b79a8cba0244e0ac15387
https://pubmed.ncbi.nlm.nih.gov/35693603
https://pubmed.ncbi.nlm.nih.gov/35693603
Autor:
Ying Lin, Xinyu Xu, Zichun Chen, Xiaolan Lai, Xiukang Wang, Xianguo Fu, Qi Chen, Chengjun Nie, Yirong Tang, Chuanqian Huang, Xuekun Nie, Renli Chen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Multiple myeloma (MM) is a malignant cancer with an increasing in incidence that can be alleviated through bortezomib (BTZ) treatment. Activating transcription factor 3 (ATF3) plays a major role in cancer development. Moreover, microRNAs (miRNAs) reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80629c1ccee4e2e761cc3cdcfb107e3a
https://www.frontiersin.org/articles/10.3389/fonc.2021.720261/full
https://www.frontiersin.org/articles/10.3389/fonc.2021.720261/full